Why Vertex's Stock Is Trading Lower Today

Vertex Pharmaceuticals Incorporated VRTX shares are trading lower on Tuesday after getting a downgrade.

RBC analysts downgraded the company's stock from Outperform to Sector Perform.

Vertex is a biopharmaceutical company based in Boston, Massachusetts.

Vertex shares were trading down 4.64% at $256.04 at time of publication on Tuesday. The stock has a 52-week high of $277.80 and a 52-week low of $164.07.

Related Link:

Vertex To Acquire Diabetes Treatment Company Semma Therapeutics For $950M